9 October 2024
LEI: 213800RG7JNX7K8F7525
Life Science REIT plc
("Life Science REIT"
or the "Company")
Pro Cam re-commits to Cambourne
Park
Life Science REIT (LSE: LABS), the real estate
investment trust focused on UK life sciences properties, announces
that Pro Cam UK Limited ("Pro Cam"), an agri-tech business, has
signed an Agreement for Lease over 4,300 sq ft of space at Building
2030, at Cambourne Park Science & Technology Campus ("Cambourne
Park"). The lease becomes effective on completion of Pro Cam's fit
out of its new space, which is expected to be in
December.
Pro Cam, which is relocating from Building 2020
where it currently occupies 7,400 sq ft, has agreed a new five year
lease at an increased rent of £25.0 psf, up 8.2% compared to its
current rent of £23.1 psf. The rent will increase to £30.0 psf in
year four.
This transaction also creates an opportunity
for further fully fitted lab repurposing. The space Pro Cam is
vacating is on the second floor at Building 2020, where Life
Science REIT is currently delivering four fully fitted labs, due to
complete in Q424. Interest in the space has been very encouraging,
with all four suites currently the subject of lease negotiations.
The project delivers a yield on cost of c. 7% and a profit on cost
of c. 25%.
With a strong uptick in occupier interest since
the start of the second half, over 90% of the 44,500 sq ft of
vacant space at Cambourne Park is now under offer or in advanced
negotiations.
Ian Harris,
Director of Asset Management at Ironstone Asset Management, the
Company's Investment Adviser, said: "Pro Cam is
a great example of the diversity of life science occupier we are
attracting to the park, and supporting existing occupiers with
their space requirements as they evolve, is a key element of our
strategy. Pro Cam's move also creates a future opportunity to do
more fully fitted lab space, which delivers attractive returns for
the Company and further establishes Cambourne as a major life
sciences destination."
Established in 1979, Pro Cam has built up a
network of specialist regional businesses covering the whole of the
UK who work with producers to increase the yield from their arable
businesses. It has expanded in recent years to include crop
nutrition, precision farming and biological
products.
Cambourne Park was acquired in 2021 with the
intention of repositioning it as a dedicated science and technology
hub. It comprises six buildings over 230,000 sq
ft.
END
Enquiries:
Ironstone Asset Management - Investment
Adviser
|
+44 20 3011 2160
|
Simon Farnsworth, Managing
Director
Simon.farnsworth@ironstoneam.com
|
|
Joanna Waddingham, Head of Investor
Relations and Corporate Affairs
|
|
Joanna.Waddingham@ironstoneam.com
|
|
|
|
Link Company Matters Limited - Company
Secretary
|
|
labs_cosec@linkgroup.co.uk
|
|
|
|
Panmure Gordon (UK) Limited - Joint Corporate
Broker
|
+44 20 7886 2500
|
Alex Collins / Tom
Scrivens
|
|
|
|
Jefferies International Limited - Joint Corporate
Broker
|
+44 20 7029 8000
|
Tom Yeadon / Oliver
Nott
|
|
G10
Capital Limited - AIFM
|
+44 20 7397 5450
|
Maria Baldwin
|
|
FTI
- Financial PR
|
+44 20 3727 1000
|
Dido Laurimore/ Richard Gotla /
Oliver Parsons
|
|
LifeScienceReit@fticonsulting.com
|
|
Notes to editors
Life Science REIT plc is a specialist
property business focused on the UK's growing life science sector.
The Company's portfolio of assets is located across the "Golden
Triangle" of research and development hubs in Oxford, Cambridge and
London's Knowledge Quarter and its strategic vision is to become
the property provider of choice for life science companies in the
UK.
Life Science REIT is addressing the
acute demand-supply imbalance for laboratory space in the "Golden
Triangle", which is characterised by low vacancy rates and prime
rental increases. The UK life science sector itself is underpinned
by strong structural drivers, including an ageing population and a
supportive regulatory environment as well as the growing
interdependence with technology, which is expanding the life
science spectrum, driving strong demand for laboratory
space.
The Company's diverse portfolio of
assets ranges from a 20-acre science park currently under
development through to fully let buildings, with an important part
of the Company's strategy being the conversion of existing
properties to laboratory space.
The Company's investment policy is
focused on capital growth whilst also providing a growing level of
income.
Life Science REIT trades on the Main
Market of the London Stock Exchange under the ticker
LABS.
Further information is available
at https://lifesciencereit.co.uk.
To sign up for email alerts, please visit https://lifesciencereit.co.uk/investors/.